| 摘要 |
Ophthalmologic vehicle system comprises: (a) >= 30-99.95 wt.% at least one fatty acid ester; and (b) 0.05-50 wt.% at least one emulsifier for the permeation and/or drug delivery of the ophthalmic active agents through the cornea and/or the sclera of the eye of a mammal for preventing and/or treating disorders of the anterior and/or posterior eye segment. Independent claims are also included for: an ophthalmologic kit comprising ophthalmological vehicle system and an ophthalmic drug formulation as separate formulations; and #a fluid dispenser for a sterile fluid, comprising a passageway with an inlet opening for a fluid present in a supply container made of flexible material and a discharge port for discharging the fluid, which has at least one oligodynamically active substance which is in contact with the fluid, a dosing pump which operates without air pressure compensation, comprising an inlet valve for closing the inlet opening, where inlet valve comprises material capable of interacting with the fluid via oligodynamically active substance, a spring device which is in contact with the fluid, where the inlet valve and the spring device comprise a stainless steel material as oligodynamically active substance, a decontamination device provided in the upper part the discharge port, and material capable of interacting with the fluid comprises silver, silver salts, other silver compounds, alloys and their nanomers in metallic or salt form, or as a chemical compound. ACTIVITY : Ophthalmological; Antiinflammatory; Neuroprotective; Cytostatic. Test details are described but no results given. MECHANISM OF ACTION : None given. |
